leisure time -WSS

leisure time

author：knowledge 2025-09-07 17:20:42 - browse：464

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Study gives hint on South Asians’ higher risk of cardiovascular disease

WSS

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Long Covid research funding gets a major boost from NIH

Vaccine advisory panel ACIP left half staffed by HHS

Gilead might be held responsible for not developing a drug

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Medicare Advantage proposed rates disappoint insurers

focus

leisure time

explore

Drug repurposing or repositioning? The language matters

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Key House Republican on health care plans exit from Congress

In age of alternative facts, a scholarly course on calling out crap

Senators start work on Medicare physician payment reform

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Jerome Adams on the need for new antivirals for Covid

Too many hospitalized Covid

entertainment

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Gilead might be held responsible for not developing a drug

Report cites 'urgent' need to recruit more diverse clinical trial participants

Juul documents reveal insider tactics on political lobbying

Biogen Alzheimer’s drug launch off to slow start

focus

explore

entertainment

knowledge